Institutional Ownership Eye Point Pharmaceuticals, Inc. (EYPT)
This table provides information about the institutional ownership of Eye Point Pharmaceuticals, Inc. (EYPT). We have compiled data on the 152 institutions that hold shares in the stock, with a total of 58 Million shares, which have been reported (via 13F filing form) to have a value of $506 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Cormorant Asset Management, LP
Boston, MA |
Nov 14, 2024 Q3 2024 |
8,325,000
shares
|
$71.8 Million
4.66% of portfolio
|
Q2 2024
Added 20.77%
|
|
Suvretta Capital Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
5,175,823
shares
|
$44.6 Million
1.63% of portfolio
|
Q2 2024
Added 37.51%
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 27, 2024 Q3 2024 |
4,012,048
shares
|
$34.6 Million
0.01% of portfolio
|
Q3 2024
Added 9.93%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2024 Q3 2024 |
3,791,420
shares
|
$32.7 Million
0.06% of portfolio
|
Q3 2024
Added 5.57%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,764,881
shares
|
$32.5 Million
0.0% of portfolio
|
Q2 2024
Added 35.07%
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
3,048,182
shares
|
$26.3 Million
0.0% of portfolio
|
Q3 2024
Added 9.87%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
2,492,213
shares
|
$21.5 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.41%
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 13, 2024 Q3 2024 |
1,923,680
shares
|
$16.6 Million
0.04% of portfolio
|
Q3 2024
Added 562.85%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
1,816,254
shares
|
$15.7 Million
0.0% of portfolio
|
Q3 2024
Reduced 19.38%
|
|
Essex Woodlands Management, Inc.
The Woodlands, TX |
Nov 14, 2024 Q3 2024 |
1,551,521
shares
|
$13.4 Million
3.56% of portfolio
|
Q1 2024
Reduced 33.63%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
1,407,353
shares
|
$12.1 Million
0.0% of portfolio
|
Q3 2024
Added 3.9%
|
|
Patient Square Capital LP
Menlo Park, CA |
Nov 14, 2024 Q3 2024 |
1,361,979
shares
|
$11.7 Million
4.04% of portfolio
|
Q3 2024
New holding
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
1,268,754
shares
|
$10.9 Million
0.01% of portfolio
|
Q3 2024
Reduced 38.75%
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,215,881
shares
|
$10.5 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.32%
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
1,215,328
shares
|
$10.5 Million
0.0% of portfolio
|
Q3 2024
Added 53.55%
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,199,056
shares
|
$10.3 Million
0.0% of portfolio
|
Q3 2024
Added 16.15%
|
|
Octagon Capital Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,093,503
shares
|
$9.43 Million
2.11% of portfolio
|
Q1 2024
New holding
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
1,050,000
shares
|
$9.05 Million
3.34% of portfolio
|
Q3 2024
Added 2000.0%
|
|
Perceptive Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
1,037,274
shares
|
$8.94 Million
0.22% of portfolio
|
Q3 2024
Added 62.0%
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
922,335
shares
|
$7.95 Million
0.96% of portfolio
|
Q2 2024
New holding
|
|
Finepoint Capital LP
Boston, MA |
Nov 13, 2024 Q3 2024 |
707,404
shares
|
$6.1 Million
0.59% of portfolio
|
Q2 2024
Added 7.74%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
647,848
shares
|
$5.58 Million
0.0% of portfolio
|
Q3 2024
Added 2.26%
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
502,965
shares
|
$4.34 Million
0.0% of portfolio
|
Q3 2024
Added 74.62%
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
471,783
shares
|
$4.07 Million
0.0% of portfolio
|
Q3 2024
Added 47.43%
|
|
Laurion Capital Management LP
New York, NY |
Nov 14, 2024 Q3 2024 |
460,006
shares
|
$3.97 Million
0.05% of portfolio
|
Q3 2024
Reduced 57.11%
|